drug · protein
patient view →vosoritide
Marketedupdated 2mo agoby $BMRN BIOMARIN PHARMACEUTICAL INC🔗 ChEMBL
Approvedcommunity read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for achondroplasia and bone disease and 2 investigational indications.
targets
Atrial natriuretic peptide receptor 2
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that